Lost your password?
Would you like to join and register to EU-Cardio?
Tenured Professor of Medicine ; Specialist physician in the area of cardiology.
University of Murcia; University Clinical Hospital Virgen de la Arrixaca.
Early career investigator (ECI):
Short biography of member:
Tenured Professor of Medicine in the University of Murcia since 2011, with two periods of six-year research and one period of five-year teaching. He is the third course coordinator, Director of the Internal Medicine Department, Board Member in the Research Commission of the University of Murcia and in the Commission of Health Sciences for Doctorate Studies. Developing his medical activity in the University Clinical Hospital Virgen de la Arrixaca, since 1999, as specialist in cardiology; and as head of the cardiology section since 2011. He has developed a wide research career, as it is reflected by the scientific activity quality indicators (H index 35, 225 indexed publications, 32 scientific projects), fundamentally in the field of biomarkers and myocardial infarction. He has been director of the doctorate program (18 doctoral thesis and several Final Projects). Besides, he is director of a University Master and director and speaker in national level training courses. He is author of several consensus documents and clinical practice guides (11). He has been President of the Murcia Cardiology Society, Board Member representing affiliated societies in the Executive Board of the Spanish Cardiology Society and currently, he is fellow of the European Society of Cardiology, member of the editorial committee of the Revista Española de Cardiología, scientific reviewer for international journals and expert evaluator for the ANEP (MINECO) and the ISCIII.
Member of the editorial committee of the Revista Española de Cardiología, scientific reviewer for international journals like JACC, Circulation and EHJ, and expert evaluator for the ANEP (MINECO) and the ISCIII. Orcid ID: orcid.org/0000-0002-4993-9540 and Scopus Author ID: 6603059758
Pascual-Figal DA, Ferrero-Gregori A, Gomez-Otero I, Vazquez R, Delgado-Jimenez J, Alvarez-Garcia J, et al. Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure. Int J Cardiol. 2017 Aug 1;240:265–70.
Fernandez-Gasso L, Hernando-Arizaleta L, Palomar-Rodríguez JA, Abellán-Pérez MV, Pascual-Figal DA. Trends, causes and timing of 30-day readmissions after hospitalization for heart failure: 11-year population-based analysis with linked data. Int J Cardiol. 2017 Dec 1;248:246–51.
Fernández Gassó ML, Hernando-Arizaleta L, Palomar-Rodríguez JA, Soria-Arcos F, Pascual-Figal DA. Trends and Characteristics of Hospitalization for Heart Failure in a Population Setting From 2003 to 2013. Rev Esp Cardiol (Engl Ed). 2017 Sep;70(9):720–6.
Pascual-Figal DA. Neprilysin and Heart Failure. J Am Coll Cardiol. 2017;70(17):2154–6.
Pascual-Figal DA. Acute heart failure and biomarkers: time also matters, don’t relax. Eur J Heart Fail. 2017 Aug;19(8):1011–3.
Asensio-Lopez MC, Lax A, Sanchez-Mas J, Avellaneda A, Planes J, Pascual-Figal DA. Reformulated meat products protect against ischemia-induced cardiac damage. Food Funct. 2016 Feb;7(2):992–1001.
Sánchez-Más J, Lax A, Asensio-López MC, Fernández-Del Palacio MJ, Caballero L, Navarro-Peñalver M, et al. The TBX1 Transcription Factor in Cardiac Remodeling After Myocardial Infarction. Rev Esp Cardiol (Engl Ed). 2016 Nov;69(11):1042–50.
Pérez-Calvo J-I, Morales-Rull J-L, Gimeno-Orna J-A, Lasierra-Díaz P, Josa-Laorden C, Puente-Lanzarote J-J, et al. Usefulness of the Hepatocyte Growth Factor as a Predictor of Mortality in Patients Hospitalized With Acute Heart Failure Regardless of Ejection Fraction. Am J Cardiol. 2016 Aug 15;118(4):543–9.
Pascual-Figal DA, Lax A, Perez-Martinez MT, del Carmen Asensio-Lopez M, Sanchez-Mas J, GREAT Network. Clinical relevance of sST2 in cardiac diseases. Clin Chem Lab Med. 2016 Jan 1;54(1):29–35.
Lax A, Sanchez-Mas J, Asensio-Lopez MC, Fernandez-Del Palacio MJ, Caballero L, Garrido IP, et al. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction. JACC Heart Fail. 2015 Jan;3(1):50–8.
Sánchez-Más J, Lax A, Asensio-López MDC, Fernandez-Del Palacio MJ, Caballero L, Santarelli G, et al. Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers. Eur J Clin Invest. 2014 Jul;44(7):643–51.
Pérez-Calvo J-I, Ruiz-Ruiz FJ, Manzano-Fernández S, Morales-Rull JL, Carrasco-Sánchez FJ, Amores-Arriaga B, et al. Renal function measurements and mortality in patients with acute heart failure. Int J Cardiol. 2013 Oct 12;168(5):4990–1.
Pascual-Figal DA, Tornel PLPL, Nicolás F, Sánchez-Más J, Martínez MDMD, Gracia MR, et al. Sex hormone-binding globulin: a new marker of disease severity and prognosis in men with chronic heart failure. Rev española Cardiol. 2009 Dec;62(12):1381–7.
Pascual-Figal DA, Bonaque JC, Redondo B, Caro C, Manzano-Fernandez S, Sanchez-Mas J, et al. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Hear Fail. 2009 Sep;11(9):840–6.
Pascual-Figal DA, Sánchez-más J, Morena D, Casas T, Garrido IPIP, Ruipérez JA, et al. Pulmonary surfactant protein B in the peripheral circulation and functional impairment in patients with chronic heart failure. Rev española Cardiol. 2009 Feb;62(2):136–42.
Vazquez R, Bayes-Genis A, Cygankiewicz I, Pascual-Figal D, Grigorian-Shamagian L, Pavon R, et al. The MUSIC Risk score: A simple method for predicting mortality in ambulatory patients with chronic heart failure. Eur Heart J. 2009 May;30(9):1088–96.
Pascual-Figal DA, Ordoñez-Llanos J, Tornel PL, Vázquez R, Puig T, Valdés M, et al. Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2009 Dec 1;54(23):2174–9.
Pascual-Figal D a, Domingo M, Casas T, Gich I, Ordoñez-Llanos J, Martínez P, et al. Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. Eur Heart J. 2008 Apr;29(8):1011–8.
Pascual-Figal DA, Penafiel P, De La MG, Redondo B, Nicolas F, Casas T, et al. Relation of B-type natriuretic peptide levels before and after exercise and functional capacity in patients with idiopathic dilated cardiomyopathy. AmJCardiol. 2007 May 1;99(0002–9149 (Print)):1279–83.
Pascual-Figal DA, Antolinos MJ, Bayes-Genis A, Casas T, Nicolas F, Valdés M. B-type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humans. Heart. 2007 Sep;93(9):1077–80.
Pascual-Figal DA, Hurtado-Martínez J a, Redondo B, Antolinos MJ, Ruiperez J a, Valdes M. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail. 2007 May;9(5):518–24.
Pascual-Figal DA, Tornel PL, Valdes M. Letter by Pascual-Figal et al regarding article, “Anabolic deficiency in men with chronic heart failure: Prevalence and detrimental impact on survival” . Circulation. 2007;115(21).
Pascual DA, Arribas JM, Tornel PL, Marín F, Oliver C, Ahumada M, et al. Preoperative Statin Therapy and Troponin T Predict Early Complications of Coronary Artery Surgery. Ann Thorac Surg. 2006 Jan;81(1):78–83.